AllSquare Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
VF
AllSquare Wealth Management's BTAL Position: Q4 2017 in Review
AllSquare Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2017, closing a stake of 355 shares — an estimated $7K sold.
AllSquare Wealth Management first reported a position in BTAL in Q1 2016 and held it in 6 quarters. The position peaked at $8K in Q2 2016. 5 funds tracked by Wall St. Rank hold BTAL as of Q4 2017.
- AllSquare Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2017 after selling out during the quarter.
- AllSquare Wealth Management sold 355 AGF US Market Neutral Anti-Beta Fund shares in Q4 2017, an estimated $7K.
- AllSquare Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2016 and held it in 6 quarters.
- AllSquare Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $8K in Q2 2016.
- 5 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2017.
Based on AllSquare Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.